2024 Benjamin McAllister Scholars
-
The Benjamin McAllister Research Scholar is a tranformational oneyear program intended for outstanding young scientists, in loving memory of Benjamin McAllister. We are excited to announce this year's awardee, Zhong Huang, MD Candidate '26. Zhong Huang (he/him) is a fourth-year medical student and a 2024 - 2025 Pritzker and Northshore Fellow under the mentorship of Dr. Peter O'Donnell. Zhong is interested in how new medical evidence, such as genetics-based prescribing data, can be adopted into routine patient care. His work aims to ensure that patients who are going through difficult medical treatments, like Ben did, receive the highest quality of care. Zhong has discovered several opportunities for intervention — ranging from provider education to care team composition — that can promote the use of cutting-edge genetic evidence. He is currently studying how this data affects provider decision-making and patient outcomes. For this work, Zhong was awarded the 2024 American Society for Clinical Pharmacology & Therapeutics Presidential Trainee Award. Prior to medical school, Zhong graduated from Duke University and worked as a health IT consultant to the Office of the National Coordinator for Health IT and the Centers for Disease Control and Prevention. He is clinically interested in end-of-life care and plans to pursue a clinical career in oncology. In his free time, Zhong is involved in his community, volunteering at four student-run free clinics throughout the greater Chicagoland area. The Benjamin McAllister Scholars program is continuing to develop, train, and inspire the most talented scientists of the next generation. Ben's legacy is changing the world, one scholar at at time.
-
Young is currently undertaking a Clinical Pharmacology and Pharmacogenomics Postdoctoral Fellowship at the University of Chicago. Since June of 2023, he has been working in the Dr. Peter O'Donnell lab, where he has been actively engaging in projects that are designed to make a significant impact in the lives of those affected by cancer.
Young has been designing and establishing a new clinical trial which investigates the role of preemptive CYP2D6 genotyping for opioid prescription in the cancer population. He has also been retrospectively analyzing the significance of CYP2D6 profiles in the post-surgical population, including hundreds of individuals undergoing surgery for cancer. Along with this lab work, he is involved in database improvements as well, working to design and build a patient-facing pharmacogenomics portal.
Before his time in the O'Donnell lab, Young received his PharmD from Northeastern University in Boston, MA, and his masters degree in Translational Medicine from the University of California San Francisco/University of California Berkeley. He held a position as a Teachers Assistant in General Genetics at University of California Berkeley and has studied and trained all over the world.
It is an honor for him to carry on Ben’s legacy—a legacy that will continue to develop, train, and inspire the most talented scientists of the next generation.
Past Scholars
-
Riley Hamilton 2023-2025
Description goes here -
Emily Smith 2021 - 2022
-
Mayher Kaur 2020
-
Natalie Reizine, MD 2019 - 2021
-
Maimouna Traore, MD 2019 - 2020
-
Tien Tuong, PharmaD, PhD 2018 - 2020
-
Annabel Boeke, MD 2017 - 2018
-
CJ Christian, MD 2017 - 2018
-
Noura Choudhury, MD 2017 - 2018